First Time Loading...

TherapeuticsMD Inc
NASDAQ:TXMD

Watchlist Manager
TherapeuticsMD Inc Logo
TherapeuticsMD Inc
NASDAQ:TXMD
Watchlist
Price: 2.03 USD 3.57% Market Closed
Updated: May 9, 2024

TherapeuticsMD Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

TherapeuticsMD Inc
Operating Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
TherapeuticsMD Inc
NASDAQ:TXMD
Operating Income
-$8.5m
CAGR 3-Years
62%
CAGR 5-Years
42%
CAGR 10-Years
10%
Johnson & Johnson
NYSE:JNJ
Operating Income
$24.3B
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Operating Income
$10.5B
CAGR 3-Years
14%
CAGR 5-Years
6%
CAGR 10-Years
12%
Pfizer Inc
NYSE:PFE
Operating Income
$10.6B
CAGR 3-Years
-6%
CAGR 5-Years
11%
CAGR 10-Years
-5%
Merck & Co Inc
NYSE:MRK
Operating Income
$6.1B
CAGR 3-Years
-12%
CAGR 5-Years
-13%
CAGR 10-Years
-3%
Eli Lilly and Co
NYSE:LLY
Operating Income
$11.3B
CAGR 3-Years
19%
CAGR 5-Years
15%
CAGR 10-Years
9%

See Also

What is TherapeuticsMD Inc's Operating Income?
Operating Income
-8.5m USD

Based on the financial report for Dec 31, 2023, TherapeuticsMD Inc's Operating Income amounts to -8.5m USD.

What is TherapeuticsMD Inc's Operating Income growth rate?
Operating Income CAGR 10Y
10%

The average annual Operating Income growth rates for TherapeuticsMD Inc have been 62% over the past three years , 42% over the past five years , and 10% over the past ten years .